Providing Space for Life Innovation
Warren Avenue Investors, founded in 2017 by President Matthew McDevitt, is a corporate real estate development and investment company specializing in the life sciences industry.
From start-ups to big corporate companies, Warren Avenue Investors has expertise in high quality properties across the country and internationally.
With over 30 years of experience in commercial life sciences real estate, Matthew McDevitt is an industry expert.
Prior to starting Warren Avenue Investors, Matthew served as one of the Founders and the Executive Vice President for one of the leading providers of real estate in the life sciences industry for over 12 years, BioMed Realty. During his time there, he maximized the shareholder value, growing it from $475 million public offering to an $8 billion sale to Blackstone.
Matthew served as President of McDevitt Real Estate Services, Inc. (MRES). MRES was a full service real estate brokerage firm focusing on the life sciences industry. He also spent 10 years as a commercial real estate broker on the I-270 Corridor, now known as “DNA Alley”.
As Chief Investment Officer, Eli oversees all investment activity for Warren Avenue, including acquisitions, financings, developments, dispositions, and asset management.
Prior to joining Warren Avenue, Eli opened the Philadelphia office of Gazit Horizons, the private North American subsidiary of Gazit Globe (TSE: GZT). With Gazit, Eli sourced and underwrote new acquisition opportunities and managed the operations and redevelopment of a local portfolio.
Before Gazit, Eli spent several years with Eastdil Secured, a leading investment sales and real estate investment bank. During his time with Eastdil, Eli valued more than $10.6Bn of real estate and worked on over $3Bn of closed equity and debt transactions. Eli transitioned to Eastdil from Federal Realty Investment Trust, where he supported the company’s 102 asset, $13Bn portfolio through underwriting investment opportunities and strategic corporate initiatives. Eli graduated from the University of Miami.
As Chief Financial Officer, Mike oversees all accounting, finance, audit, and performance functions of the Warren Avenue platform.
Prior to joining Warren Avenue Investors, Mike spent 27 years with Toll Brothers (NYSE: TOL) — the nation’s largest luxury homebuilder — most recently serving as their Vice President and Corporate Controller. While with Toll Brothers, Mike was responsible for treasury management, payroll, financial planning and analysis and reporting, as well as corporate credit and surety bond programs. Mike’s areas of focus spanned the company’s corporate structure as well as wholly owned and joint venture developments. Throughout his career, Mike has played a key role in M&A, system implementations, change management, and leadership development.
Mike is a graduate of the Drexel University, a Certified Public Accountant, and a proud parent of four children with his wife Kathy. He is an active volunteer at various community and youth athletic organizations.
As COO, Ryan applies his experience and knowledge of major players and emerging therapies/technologies in the life sciences space to strategize and implements company initiatives, including tenant analysis, new investment opportunities and business development.
Before Warren Avenue, Ryan held a position with The Discovery Labs, the world’s largest and most advanced single solution cell and gene therapy contract development and manufacturing organization (CDMO). As an investment analyst, Ryan worked to create complex partnership agreements with potential clients.
Before The Discovery Labs, Ryan began his career with BioMed Realty Trust, working within the Leasing and Development department. During his time at BioMed, Ryan supported the company navigate various regulatory, operational, and financial objectives. Ryan graduated from Villanova University.
As Vice President of Construction & Development, Mark oversees all design and construction activities for Warren Avenue projects across the country. Mark works closely with our Investments, Finance, and Property Management teams in developing strategies and executing business plans to maximize tenant productivity.
Prior to joining Warren Avenue, Mark spent nearly a decade with Turner Construction Company – the largest domestic contractor in the United States. During his time at Turner, Mark lead projects ranging from multi-use commercial high rises to pharmaceutical lab spaces. Mark successfully launched Turner’s new Delaware office and expanded the company’s production in the region
Mark brings his understanding of the building process and financial strategies in construction to maximize project value. Mark earned a Bachelor of Science in Civil Engineering from Villanova University and is a licensed Professional Engineer (Structural) in the state of Pennsylvania.
As Vice President of Property Management, Tina is responsible for overseeing the operational and management functions of the Warren Avenue Investors portfolio.
In leading the Property Management team, she ensures financial and operational standards are consistently met for investors and tenants, alike. Tina’s strong tenant relationships are critical to the success of Warren Avenue Investors, having worked with Johnson & Johnson, Charles River Labs, Flamma Group, Venatorx, and Coram (CVS Health), to name a few. With over 15 years of life sciences real estate experience, Tina also supports the Warren Avenue platform through business development, marketing, leasing, acquisitions, and dispositions of life sciences real estate across the country. Prior to joining Warren Avenue Investors, Tina held positions with BioMed Realty Trust, Transwestern Life Sciences Asset Services, Healthcare Realty, and Main Line Health.
Tina received a Bachelor’s Degree in Business Administration from Edinboro University of Pennsylvania and holds a Pennsylvania Real Estate Salesperson License. She is currently a candidate for a Master’s in Business Administration from West Chester University of Pennsylvania
As Investment Associate, Phil applies his industry experience and critical thinking to support all for Warren Avenue’s investment activity. This includes the analysis of potential acquisitions and developments, as well as financings, dispositions, leasing, and asset management.
Prior to joining Warren Avenue, Phil was a financial analyst with Equus Capital Partners. With Equus, Phil supported the acquisition, disposition, recapitalization, and development of approximately $2.5Bn in transaction volume across multiple product types. He also assisted in the asset management of over 1 million square feet of commercial property.
Phil studied at Villanova University where he graduated with a degree in Finance and Real Estate.